(Abstracted from N Engl J Med 2018;379:1905–1914)
Women diagnosed with early-stage cervical cancer often undergo frontline radical hysterectomy, which has been associated with a cure rate of greater than 80% in stage IA2 and IB1 disease. Radical hysterectomy has been traditionally performed as open surgery.
Division of Gynecologic Oncology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School (A.M., M.G.C.); Department of Health Care Policy, Harvard Medical School (N.L.K.); Division of General Internal Medicine, Brigham and Women's Hospital (N.L.K.), Boston, MA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Prentice Women's Hospital (D.J.M., J.Y., B.-L.L.S., A.A., E.L.B., M.K., S.S.), and Division of Biostatistics, Department of Preventive Medicine (M.K.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Department of Obstetrics and Gynecology and Herbert Irving Comprehensive Cancer Center, Columbia University, and New York Presbyterian Hospital, New York, NY (L.C., J.D.W.); Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, WI (L.W.R.); and Departments of Gynecologic Oncology and Reproductive Medicine and Health Services Research, University of Texas M. D. Anderson Cancer Center, Houston, TX (J.A.R.-H.)